Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Clinicopathological and molecular characteristics of primary renal Ewing sarcoma: an analysis of seventeen cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology·2026
Same author

[Safety and feasibility of mobile double suspension technique in pure single-port laparoscopic D2 radical gastrectomy for distal gastric cancer].

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery·2026
Same author

[Spontaneous remission of primary aldosteronism: a case series of three patients and literature review].

Zhonghua nei ke za zhi·2026
Same author

[Advances in all-oral short-course regimens for drug-resistant tuberculosis].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases·2026
Same author

[A 2-year follow-up clinical study on the multidisciplinary comprehensive treatment of burning mouth syndrome].

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology·2026
Same author

[Comparative analysis of long-term efficacy between the CCCG-ALL-2015 and CCLG-ALL-2008 protocols in adolescents with acute lymphoblastic leukemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026
Same journal

[The era of precision diagnosis and treatment for optic neuritis: advances in diagnostic classification, biomarkers and therapeutic strategies].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2026
Same journal

[Application value of ocular multimodal imaging methods in the evaluation of increased intracranial pressure].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2026
Same journal

[Secondary panuveitis after ocular wasp sting: a case report].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2026
Same journal

[Correlation of ocular surface changes with filtering bleb morphology after antiglaucoma surgery for primary angle-closure glaucoma].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2026
Same journal

[Regulation of SARM1 on SNPH expression and its participation in glaucomatous optic neuropathy].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2026
Same journal

[Construction of a regulated <i>Crat</i> overexpression system in mouse hippocampal neuronal HT22 cell line].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2026
See all related articles

Related Experiment Video

Updated: Jan 18, 2026

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.2K

[Research progress on pathologic myopic macular atrophy].

J X Wang1, W B Wei1

  • 1Beijing Tongren Eye Center, Beijing Institute of Ophthalmology, Beijing Ophthalmology＆Visual Sciences Key Lab, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.

[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
|September 8, 2025
PubMed
Summary
This summary is machine-generated.

Pathological myopia causes irreversible vision loss, with macular atrophy being a key feature. Choroidal neovascularization is linked to macular atrophy, but effective treatments are currently unavailable.

More Related Videos

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
08:54

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow

Published on: May 26, 2023

2.1K
A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration
09:24

A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration

Published on: March 10, 2023

2.4K

Related Experiment Videos

Last Updated: Jan 18, 2026

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.2K
Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
08:54

Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow

Published on: May 26, 2023

2.1K
A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration
09:24

A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration

Published on: March 10, 2023

2.4K

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Myopia Research

Background:

  • Pathological myopia is a leading cause of irreversible vision loss.
  • Myopic maculopathy, particularly macular atrophy, significantly contributes to severe visual impairment.
  • The exact mechanisms driving macular atrophy development are not fully understood.

Purpose of the Study:

  • To review the current understanding of macular atrophy in pathological myopia.
  • To explore the relationship between choroidal neovascularization and macular atrophy.
  • To identify gaps in therapeutic interventions for macular atrophy.

Main Methods:

  • Literature review of studies on pathological myopia and macular atrophy.
  • Analysis of research linking choroidal neovascularization to macular atrophy progression.
  • Synthesis of current knowledge on treatment strategies.

Main Results:

  • Macular atrophy is a primary cause of severe vision impairment in pathological myopia.
  • Choroidal neovascularization is strongly associated with the development and progression of macular atrophy.
  • No effective therapies currently exist to halt or reverse macular atrophy.

Conclusions:

  • Understanding the link between choroidal neovascularization and macular atrophy is crucial.
  • Further research is needed to develop effective treatments for pathological myopia-related macular atrophy.
  • Addressing this condition is vital to prevent irreversible visual loss.